期刊文献+

巴比妥经不同皮肤层吸收差异的评价(英文)

Influence of different layers of skin on the percutaneous absorption of barbital
下载PDF
导出
摘要 目的 评价皮肤角质层和活性皮肤层对药物经皮吸收的差异。方法 选择巴比妥(BB)为模型药物,采用Franz吸收池法,考察药物经完整皮肤和剥离角质层皮肤的体外透皮能力Kp,并比较吸收促进剂肉豆蔻酸异丙酯(IPM)共存时的促透能力大小。结果 BB经剥离角质层皮肤的Kp是经完整皮肤的2.37倍,加入IPM后BB的Kp分别提高到原来的2.59倍(经完整皮肤)和6.92倍(经剥离角质层皮肤)。结论 本实验为皮肤病态条件,如皮肤受伤或溃疡等时的药物经皮吸收提供实验依据。 Objective: To investigate the influence of skin layers (stratum corneum and viable layer) on the percutaneous absorption of drug with or without isopropyl myristate (IPM). Methods: Barbital (BB) was chosen as a model drug. Patches containing saturated concentration of BB were prepared. The in vitro percutaneous permeation experiment via different rat skin layers was carried out. Results:The Kp of BB via stripped skin was 2.37 times larger than that via intact skin. The permeability was enhanced when coexisting with IPM via both intact skin and stripped skin. Conclusions:These data and methods could be a novel approach to evaluate the effects of skin damage and skin disease on drug percutaneous absorption.
出处 《中国现代医学杂志》 CAS CSCD 2004年第12期49-52,共4页 China Journal of Modern Medicine
关键词 巴比妥 肉豆蔻酸异丙酯 剥离角质层 经皮吸收 barbital isopropyl myristate stratum corneum stripped skin in vitro percutaneous absorption
  • 相关文献

参考文献7

  • 1[1]Banie CF, Timothy MM. Transdermal penetration enhancers: applications, limitations, and potential [J]. J Pharm Sci, 1999,88(10) :955.
  • 2[2]Blank IH, Maloney J, Emslie AG, et al. The diffusion of water across the stratum corneum as a function of its water content [J]. J Invest Dermatol, 1984,82:188.
  • 3[3]Johnson ME, Mitragotri S and Patel A. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery [J]. J Pharm Sci, 1996,85(7) :670.
  • 4[4]LEE CK, Uchida T, Kitugawa K, et al. Skin permeability of various drugs with different lipophilicity [J]. J Pharm Sci, 1994,83(4): 562.
  • 5[5]Campbell RL, Bruce RD. Comparative dermatotoxicology: direct comparison of rabbit and human primary skin irritation responses to isopropyl myristate [J]. Toxicol Pharmacol, 1981,59: 555.
  • 6[6]Sato K, Sugibayashi K, Morimoto Y. Effect and mode of action of aliphatic esters on the in vitro permeation of nicorandil [J]. Int J Pharm, 1988, 43:31 -40
  • 7[7]Claudi AS, Bernhard CL. An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with diffefential scanning calorimetry [J]. J Pharrn Pharrnacol, 1995, 47:276- 281.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部